Axon Enterprise, Inc $AXON Stake Increased by CoreCap Advisors LLC

CoreCap Advisors LLC boosted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 1,803.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 27,049 shares of the biotechnology company’s stock after purchasing an additional 25,628 shares during the period. CoreCap Advisors LLC’s holdings in Axon Enterprise were worth $11,429,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of AXON. Atwood & Palmer Inc. grew its position in Axon Enterprise by 183.3% in the 3rd quarter. Atwood & Palmer Inc. now owns 1,473 shares of the biotechnology company’s stock valued at $622,000 after acquiring an additional 953 shares during the last quarter. Everhart Financial Group Inc. increased its stake in Axon Enterprise by 4,709.9% in the third quarter. Everhart Financial Group Inc. now owns 22,270 shares of the biotechnology company’s stock worth $9,410,000 after purchasing an additional 21,807 shares during the period. Avidian Wealth Enterprises LLC lifted its position in shares of Axon Enterprise by 3,661.6% during the third quarter. Avidian Wealth Enterprises LLC now owns 62,818 shares of the biotechnology company’s stock worth $26,542,000 after purchasing an additional 61,148 shares during the last quarter. Toth Financial Advisory Corp lifted its position in shares of Axon Enterprise by 99.2% during the third quarter. Toth Financial Advisory Corp now owns 747 shares of the biotechnology company’s stock worth $316,000 after purchasing an additional 372 shares during the last quarter. Finally, Elevation Wealth Partners LLC boosted its stake in shares of Axon Enterprise by 12,450.0% during the third quarter. Elevation Wealth Partners LLC now owns 3,263 shares of the biotechnology company’s stock valued at $1,379,000 after purchasing an additional 3,237 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 2.8%

Shares of Axon Enterprise stock traded up $11.31 during trading on Thursday, hitting $417.31. 1,570,770 shares of the stock traded hands, compared to its average volume of 1,056,396. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The stock’s fifty day simple moving average is $522.70 and its 200 day simple moving average is $477.18. The firm has a market cap of $33.90 billion, a P/E ratio of 173.16, a price-to-earnings-growth ratio of 7.88 and a beta of 1.44. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $764.02.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. During the same period in the prior year, the firm earned $2.12 earnings per share. The firm’s revenue for the quarter was up 35.3% compared to the same quarter last year. On average, equities analysts predict that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently commented on AXON shares. Barclays raised their price target on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Citigroup restated a “market outperform” rating on shares of Axon Enterprise in a research note on Thursday, September 17th. Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, September 2nd. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $721.57.

Insider Buying and Selling at Axon Enterprise

In other news, insider Jeffrey Kunins sold 9,605 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares in the company, valued at approximately $61,266,818.70. The trade was a 8.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares of the company’s stock, valued at $27,032,038.80. The trade was a 1.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 47,397 shares of company stock worth $26,722,984. 4.20% of the stock is owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.